271 related articles for article (PubMed ID: 34220834)
21. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
[TBL] [Abstract][Full Text] [Related]
22. Autophagy occurs in lymphocytes infiltrating Sjögren's syndrome minor salivary glands and correlates with histological severity of salivary gland lesions.
Colafrancesco S; Vomero M; Iannizzotto V; Minniti A; Barbati C; Arienzo F; Mastromanno L; Colasanti T; Izzo R; Nayar S; Pipi E; Cerbelli B; Giordano C; Ciccia F; Conti F; Valesini G; Barone F; Priori R; Alessandri C
Arthritis Res Ther; 2020 Oct; 22(1):238. PubMed ID: 33050949
[TBL] [Abstract][Full Text] [Related]
23. Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis.
Ulrich C; Trojanowicz B; Fiedler R; Kohler F; Wolf AF; Seibert E; Girndt M
Nephron; 2017; 135(3):231-241. PubMed ID: 27992874
[TBL] [Abstract][Full Text] [Related]
24. Measurement of Lipoprotein-Associated Phospholipase A2 by Use of 3 Different Methods: Exploration of Discordance between ELISA and Activity Assays.
Topbas C; Swick A; Razavi M; Anderson NL; Pearson TW; Bystrom C
Clin Chem; 2018 Apr; 64(4):697-704. PubMed ID: 29321128
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
27. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults.
Detopoulou P; Nomikos T; Fragopoulou E; Panagiotakos DB; Pitsavos C; Stefanadis C; Antonopoulou S
Lipids Health Dis; 2009 Jun; 8():19. PubMed ID: 19500354
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?
Fratta Pasini A; Stranieri C; Pasini A; Vallerio P; Mozzini C; Solani E; Cominacini M; Cominacini L; Garbin U
PLoS One; 2013; 8(12):e83092. PubMed ID: 24358251
[TBL] [Abstract][Full Text] [Related]
30. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome).
Ogawa N; Dang H; Lazaridis K; McGuff HS; Aufdemorte TB; Talal N
J Interferon Cytokine Res; 1995 Sep; 15(9):759-67. PubMed ID: 8536103
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.
Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS
Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715
[TBL] [Abstract][Full Text] [Related]
32. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
33. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
[TBL] [Abstract][Full Text] [Related]
34. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome.
Hu S; Gao K; Pollard R; Arellano-Garcia M; Zhou H; Zhang L; Elashoff D; Kallenberg CG; Vissink A; Wong DT
Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1633-8. PubMed ID: 20617533
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.
Nocturne G; Virone A; Ng WF; Le Guern V; Hachulla E; Cornec D; Daien C; Vittecoq O; Bienvenu B; Marcelli C; Wendling D; Amoura Z; Dhote R; Lavigne C; Fior R; Gottenberg JE; Seror R; Mariette X
Arthritis Rheumatol; 2016 Apr; 68(4):977-85. PubMed ID: 26606524
[TBL] [Abstract][Full Text] [Related]
36. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes.
Seyfarth J; Reinehr T; Hoyer A; Reinauer C; Bächle C; Karges B; Mayatepek E; Roden M; Hofer SE; Wiegand S; Woelfle J; Kiess W; Rosenbauer J; Holl RW; Meissner T
J Inherit Metab Dis; 2018 Jan; 41(1):73-79. PubMed ID: 29027597
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
Barcellos KS; Nonogaki S; Enokihara MM; Teixeira MS; Andrade LE
J Rheumatol; 2007 Jun; 34(6):1283-92. PubMed ID: 17552056
[TBL] [Abstract][Full Text] [Related]
39. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
40. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
Zhou W; Dong Y; Zhao Y; Tang FL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
